These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8167386)

  • 1. Effect of cyclosporine A on serum tumor necrosis factor alpha in new-onset type I (insulin-dependent) diabetes mellitus.
    Burke GW; Cirocco R; Markou M; Agramonte RF; Rabinovitch A; Miller J; Skyler JS
    J Diabetes Complications; 1994; 8(1):40-4. PubMed ID: 8167386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine in recent onset type I diabetes mellitus. Effects on islet beta cell function. Miami Cyclosporine Diabetes Study Group.
    Skyler JS; Rabinovitch A
    J Diabetes Complications; 1992; 6(2):77-88. PubMed ID: 1611143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.
    Hussain MJ; Peakman M; Gallati H; Lo SS; Hawa M; Viberti GC; Watkins PJ; Leslie RD; Vergani D
    Diabetologia; 1996 Jan; 39(1):60-9. PubMed ID: 8720604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.
    Dogan Y; Akarsu S; Ustundag B; Yilmaz E; Gurgoze MK
    Mediators Inflamm; 2006; 2006(1):59206. PubMed ID: 16864906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
    Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
    Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in sera from insulin-dependent diabetic patients at diagnosis.
    Cavallo MG; Pozzilli P; Bird C; Wadhwa M; Meager A; Visalli N; Gearing AJ; Andreani D; Thorpe R
    Clin Exp Immunol; 1991 Nov; 86(2):256-9. PubMed ID: 1934594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
    Pozzilli P; Visalli N; Signore A; Baroni MG; Buzzetti R; Cavallo MG; Boccuni ML; Fava D; Gragnoli C; Andreani D
    Diabetologia; 1995 Jul; 38(7):848-52. PubMed ID: 7556988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following initial insulin treatment.
    Espersen GT; Mathiesen O; Grunnet N; Jensen S; Ditzel J
    APMIS; 1993 Sep; 101(9):703-6. PubMed ID: 8240789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum angiotensin-converting enzyme levels in patients with recent-onset insulin-dependent diabetes after one year of low-dose cyclosporin therapy. IMDIAB Study Group.
    Letizia C; d'Ambrosio C; De Ciocchis A; Scavo D; Pozzilli P
    Int J Clin Pharmacol Res; 1995; 15(5-6):209-13. PubMed ID: 8835619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM.
    el-Nawawy A; Soliman T; el-Azzouni O; Abbassy AA; Massoud MN; Marzouk S; Ibrahim F; Helal L
    Indian J Pediatr; 1998; 65(3):455-60. PubMed ID: 10771998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-dose cyclosporine prophylaxis in nonobese diabetic mice.
    Formby B; Miller N; Garret R; Peterson CM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1106-11. PubMed ID: 3298620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.
    Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
    Diabet Med; 1994; 11(1):98-104. PubMed ID: 8181261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum levels of tumor necrosis factor-alpha in insulin-dependent diabetic children.
    Lorini R; De Amici M; d'Annunzio G; Vitali L; Scaramuzza A
    Horm Res; 1995; 43(5):206-9. PubMed ID: 7782051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
    Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
    Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
    Miki H; Matsuyama T; Fujii S; Komatsu R; Nishioeda Y; Omae T
    Diabetes Res Clin Pract; 1992 Nov; 18(2):99-105. PubMed ID: 1478158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics.
    Mandrup-Poulsen T; Nerup J; Stiller CR; Marner B; Bille G; Heinrichs D; Martell R; Dupre J; Keown PA; Jenner MR
    Lancet; 1985 Mar; 1(8429):599-602. PubMed ID: 2857945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumour necrosis factor-alpha in peripheral whole blood of people at high risk of developing type 1 diabetes and people with newly diagnosed type 1 diabetes.
    Kretowski A; Myśliwiec J; Szelachowska M; Kinalski M; Kinalska I
    Diabetes Res Clin Pract; 2000 Feb; 47(2):81-6. PubMed ID: 10670906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis.
    Bunikowski R; Gerhold K; Bräutigam M; Hamelmann E; Renz H; Wahn U
    Int Arch Allergy Immunol; 2001 Aug; 125(4):344-8. PubMed ID: 11574757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus.
    Pociot F; Mølvig J; Wogensen L; Worsaae H; Dalbøge H; Baek L; Nerup J
    Scand J Immunol; 1991 Jan; 33(1):37-49. PubMed ID: 1996407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.